Wei Hu’s scientific contributions

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (1)


The expression of GRB7. (A,B) GRB7 mRNA levels in pan-cancer (A), OC (B), and the corresponding normal tissues in TCGA and GTEx databases. (C–E) GRB7’s expression in OC and normal tissues in GEO databases, GSE6008 (C), GSE36668 (D), and GSE66957 (E). (F) GRB7 protein levels in OC and paired adjacent normal tissues from cProCite database. (G) Representative results of immunochemically stained GRB7 proteins in OC and normal ovarian tissues from Human Protein Atlas. * p < 0.05; *** p < 0.001 by unpaired Student’s t test (A–F). ns, not significant.
The prognosis and diagnosis value of GRB7 in OC. (A–D) OS, DSS, DFI, and PFI curves of lowly and highly expressed GRB7 in OC. (E) Univariate and multivariate regression analyses of GRB7 and clinicopathologic factors with OS in OC patients from TCGA. (F) A nomogram to predict OS probability at 1-year, 2-year, and 3-year overall survival probabilities for OC. * p < 0.05; ** p < 0.01; *** p < 0.001 by unpaired Student’s t test (E, F). # Events represents the number of death cases.
Gene expression and enrichment of GRB7-associated gene in OC from TCGA. (A) Heatmap of top 20 genes positively correlated with GRB7 and top 20 negatively correlated genes in OC. (B) KEGG enrichment results of all 225 different expressed genes. (C) Biological processes, cellular components, and molecular functions from GO enrichment results. (D) Chord diagrams of biological processes.
The immune infiltration and association with immunotherapy response of GRB7 in OC. (A) Immune cell enrichment in low and high expression levels of GRB7 in OC from CIBERSORT. (B) GRB7’s expression levels in responders and non-responders of ICB in syngeneic mouse models. (C) Protein–protein interaction signature of GRB7 from string database. (D,E) The GRB7 signature expression level in responders and non-responders of ICB-treated clinical cohorts, PD1 + CTLA4 in melanoma (D), and PDL1 in metastatic urothelial cancer (E). (F) GRB7 knockout in cancer cells cocultured with T cells from several CRISPR-Cas9 screens. Box plots indicate median (middle line), 25th and 75th percentile (box), and 5th and 95th percentile (whiskers) (A,B,D,E), and each dot in the scatter represents an individual patient sample (D,E). * p < 0.05; ** p < 0.01; *** p < 0.001 by unpaired Student’s t test (A,B,D,E). ns, not significant.
GRB7’s expression among different cell types and datasets. The cohorts highlighted in red are the ovarian cancer single-cell datasets.

+2

GRB7 Plays a Vital Role in Promoting the Progression and Mediating Immune Evasion of Ovarian Cancer
  • Article
  • Full-text available

August 2024

·

39 Reads

·

1 Citation

Liang Wen

·

Wei Hu

·

Sen Hou

·

[...]

·

Yuanguang Meng

Background: Despite breakthroughs in treatment, ovarian cancer (OC) remains one of the most lethal gynecological malignancies, with an increasing age-standardized mortality rate. This underscores an urgent need for novel biomarkers and therapeutic targets. Although growth factor receptor-bound protein 7 (GRB7) is implicated in cell signaling and tumorigenesis, its expression pattern and clinical implications in OC remain poorly characterized. Methods: To systematically investigate GRB7’s expression in OC, our study utilized extensive datasets from TCGA, GTEx, CCLE, and GEO. The prognostic significance of GRB7 was evaluated by means of Kaplan–Meier and Cox regression analyses. Using a correlation analysis and gene set enrichment analysis, relationships between GRB7’s expression and gene networks, immune cell infiltration and immunotherapy response were investigated. In vitro experiments were conducted to confirm GRB7’s function in the biology of OC. Results: Compared to normal tissues, OC tissues exhibited a substantial upregulation of GRB7. Reduced overall survival, disease-specific survival, and disease-free interval were all connected with high GRB7 mRNA levels. The network study demonstrated that GRB7 is involved in pathways relevant to the course of OC and has a positive connection with several key driver genes. Notably, GRB7’s expression was linked to the infiltration of M2 macrophage and altered response to immunotherapy. Data from single-cell RNA sequencing data across multiple cancer types indicated GRB7’s predominant expression in malignant cells. Moreover, OC cells with GRB7 deletion showed decreased proliferation and migration, as well as increased susceptibility to T cell-mediated cytotoxicity. Conclusion: With respect to OC, our results validated GRB7 as a viable prognostic biomarker and a promising therapeutic target, providing information about its function in tumorigenesis and immune modulation. GRB7’s preferential expression in malignant cells highlights its significance in the biology of cancer and bolsters the possibility that it could be useful in enhancing the effectiveness of immunotherapy.

Download

Citations (1)


... The tumor microenvironment (TME) plays a vital role in both tumor progression and the effectiveness of immunotherapy. It was found that the knockout of GRB7 was associated with increased T cell-mediated cytotoxicity, suggesting the possibility of GRB7 being a potential target for immunotherapy [25]. In this study, the relationship between GRB7 expression and immune cell infiltration in KICH, KIRC, and PAAD was examined using the TIMER database. ...

Reference:

A Comprehensive Pan-Cancer Analysis Reveals GRB7 as a Potential Diagnostic and Prognostic Biomarker
GRB7 Plays a Vital Role in Promoting the Progression and Mediating Immune Evasion of Ovarian Cancer